Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Deepnoid Inc. (315640:KRX), powered by AI.
Deepnoid Inc. is currently trading at ₩2,205. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Deepnoid Inc. on Alpha Lenz.
Deepnoid Inc.'s P/E ratio is -6.0.
“Deepnoid Inc. trades at a P/E of -6.0 (undervalued) with modest ROE of -45.2%. 3Y revenue CAGR of 32.9% highlights clear growth momentum.”
Ask for details →Deepnoid Inc. operates as a technology company specializing in artificial intelligence (AI) and machine learning solutions across various industries. The company's core mission is to provide smart AI integrations that enhance operational efficiency and innovation. Deepnoid delivers advanced platforms that assist in data analysis, decision-making, and predictive modeling, addressing needs in industries like healthcare, finance, and manufacturing. Notably, Deepnoid Inc. focuses on developing AI tools that streamline processes, reduce errors, and drive significant cost efficiencies. In healthcare, for example, their technology aids in diagnostics and patient management, while in finance, it is used for algorithmic trading and risk assessment. Their platforms are designed to be adaptive and user-friendly, ensuring seamless integration into existing systems. Deepnoid Inc. plays a crucial role in the global AI market by pushing the envelope of what's possible with intelligent systems. Its innovation-driven approach helps industries meet rising demands for enhanced productivity and data-driven insights, positioning the company strategically in the ever-growing field of artificial intelligence solutions.
“Deepnoid Inc. trades at a P/E of -6.0 (undervalued) with modest ROE of -45.2%. 3Y revenue CAGR of 32.9% highlights clear growth momentum.”
Ask for details →Deepnoid Inc. (ticker: 315640) is a company listed on KRX in the Healthcare sector (Health Information Services). Market cap is $64.8B.
The current price is ₩2,205 with a P/E ratio of -6.03x and P/B of 2.27x.
ROE is -45.23% and operating margin is -141.29%. Annual revenue is $7.5B.